180 related articles for article (PubMed ID: 32363113)
1. Prognostic value of CD73 expression in resected colorectal cancer liver metastasis.
Messaoudi N; Cousineau I; Arslanian E; Henault D; Stephen D; Vandenbroucke-Menu F; Dagenais M; Létourneau R; Plasse M; Roy A; Lapointe R; Ysebaert D; Trudel D; Soucy G; Stagg J; Turcotte S
Oncoimmunology; 2020; 9(1):1746138. PubMed ID: 32363113
[TBL] [Abstract][Full Text] [Related]
2. Radiomics using computed tomography to predict CD73 expression and prognosis of colorectal cancer liver metastases.
Saber R; Henault D; Messaoudi N; Rebolledo R; Montagnon E; Soucy G; Stagg J; Tang A; Turcotte S; Kadoury S
J Transl Med; 2023 Jul; 21(1):507. PubMed ID: 37501197
[TBL] [Abstract][Full Text] [Related]
3. Homogeneity in immune features between colorectal liver metastases better identifies patients with good prognosis compared to pathological response to preoperative chemotherapy.
Henault D; Stephen D; St-Hilaire PA; Messaoudi N; Vandenbroucke-Menu F; Simoneau E; Rong Z; Plasse M; Létourneau R; Roy A; Dagenais M; Lapointe R; Nguyen B; Mes-Masson AM; Soucy G; Turcotte S
Oncoimmunology; 2023; 12(1):2253642. PubMed ID: 37720689
[TBL] [Abstract][Full Text] [Related]
4. Prognostic implications of adaptive immune features in MMR-proficient colorectal liver metastases classified by histopathological growth patterns.
Messaoudi N; Henault D; Stephen D; Cousineau I; Simoneau E; Rong Z; Létourneau R; Plasse M; Dagenais M; Roy A; Lapointe R; Vandenbroucke-Menu F; Kunda R; Ysebaert D; Soucy G; Stagg J; Vermeulen P; Turcotte S
Br J Cancer; 2022 May; 126(9):1329-1338. PubMed ID: 34980880
[TBL] [Abstract][Full Text] [Related]
5. Soluble CD73 as biomarker in patients with metastatic melanoma patients treated with nivolumab.
Morello S; Capone M; Sorrentino C; Giannarelli D; Madonna G; Mallardo D; Grimaldi AM; Pinto A; Ascierto PA
J Transl Med; 2017 Dec; 15(1):244. PubMed ID: 29202855
[TBL] [Abstract][Full Text] [Related]
6. Association between primary tumor characteristics and histopathological growth pattern of liver metastases in colorectal cancer.
Bohlok A; Tonneau C; Vankerckhove S; Craciun L; Lucidi V; Bouazza F; Hendlisz A; Van Laethem JL; Larsimont D; Vermeulen P; Donckier V; Demetter P
Clin Exp Metastasis; 2023 Oct; 40(5):431-440. PubMed ID: 37453024
[TBL] [Abstract][Full Text] [Related]
7. Impact of primary cancer features on behaviour of colorectal liver metastases and survival after hepatectomy.
Cucchetti A; Russolillo N; Johnson P; Tarchi P; Ferrero A; Cucchi M; Serenari M; Ravaioli M; de Manzini N; Cescon M; Ercolani G
BJS Open; 2019 Apr; 3(2):186-194. PubMed ID: 30957066
[TBL] [Abstract][Full Text] [Related]
8. BRAF mutation is not associated with an increased risk of recurrence in patients undergoing resection of colorectal liver metastases.
Bachet JB; Moreno-Lopez N; Vigano L; Marchese U; Gelli M; Raoux L; Truant S; Laurent C; Herrero A; Le Roy B; Deguelte Lardiere S; Passot G; Hautefeuille V; De La Fouchardiere C; Artru P; Ameto T; Mabrut JY; Schwarz L; Rousseau B; Lepère C; Coriat R; Brouquet A; Sa Cunha A; Benoist S
Br J Surg; 2019 Aug; 106(9):1237-1247. PubMed ID: 31183866
[TBL] [Abstract][Full Text] [Related]
9. CD73 blockade enhances the local and abscopal effects of radiotherapy in a murine rectal cancer model.
Tsukui H; Horie H; Koinuma K; Ohzawa H; Sakuma Y; Hosoya Y; Yamaguchi H; Yoshimura K; Lefor AK; Sata N; Kitayama J
BMC Cancer; 2020 May; 20(1):411. PubMed ID: 32397971
[TBL] [Abstract][Full Text] [Related]
10. Postoperative circulating tumour DNA is associated with pathologic response and recurrence-free survival after resection of colorectal cancer liver metastases.
Bolhuis K; van 't Erve I; Mijnals C; Delis-Van Diemen PM; Huiskens J; Komurcu A; Lopez-Yurda M; van den Broek D; Swijnenburg RJ; Meijer GA; Punt CJA; Fijneman RJA
EBioMedicine; 2021 Aug; 70():103498. PubMed ID: 34333237
[TBL] [Abstract][Full Text] [Related]
11. Cancer-associated stroma reveals prognostic biomarkers and novel insights into the tumour microenvironment of colorectal cancer and colorectal liver metastases.
Brown KM; Xue A; Smith RC; Samra JS; Gill AJ; Hugh TJ
Cancer Med; 2022 Jan; 11(2):492-506. PubMed ID: 34874125
[TBL] [Abstract][Full Text] [Related]
12. D-dimer predicts postoperative recurrence and prognosis in patients with liver metastasis of colorectal cancer.
Watanabe A; Araki K; Harimoto N; Kubo N; Igarashi T; Ishii N; Yamanaka T; Hagiwara K; Kuwano H; Shirabe K
Int J Clin Oncol; 2018 Aug; 23(4):689-697. PubMed ID: 29574651
[TBL] [Abstract][Full Text] [Related]
13. Infiltrative Tumor Borders in Colorectal Liver Metastasis: Should We Enlarge Margin Size?
Jayme VR; Fonseca GM; Amaral IMA; Coelho FF; Kruger JAP; Jeismann VB; Pinheiro RSN; de Mello ES; Herman P
Ann Surg Oncol; 2021 Nov; 28(12):7636-7646. PubMed ID: 33834322
[TBL] [Abstract][Full Text] [Related]
14. Decreased CD73+ Double-Negative T Cells and Elevated Level of Soluble CD73 Correlated With and Predicted Poor Immune Reconstitution in HIV-Infected Patients After Antiretroviral Therapy.
Wang X; Zhang L; Du J; Wei Y; Wang D; Song C; Chen D; Li B; Jiang M; Zhang M; Zhao H; Kong Y
Front Immunol; 2022; 13():869286. PubMed ID: 35444646
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of CD73 and A2A adenosine receptor expression in non-small-cell lung cancer.
Inoue Y; Yoshimura K; Kurabe N; Kahyo T; Kawase A; Tanahashi M; Ogawa H; Inui N; Funai K; Shinmura K; Niwa H; Suda T; Sugimura H
Oncotarget; 2017 Jan; 8(5):8738-8751. PubMed ID: 28060732
[TBL] [Abstract][Full Text] [Related]
16. [Predictors and outcomes of recurrence after resection of colorectal liver metastases].
Sun Y; Yan X; Wang K; Bao Q; Wang H; Jin K; Xing B
Zhonghua Yi Xue Za Zhi; 2014 Apr; 94(16):1232-6. PubMed ID: 24924887
[TBL] [Abstract][Full Text] [Related]
17. Dynamic monitoring of circulating tumor DNA to predict prognosis and efficacy of adjuvant chemotherapy after resection of colorectal liver metastases.
Wang DS; Yang H; Liu XY; Chen ZG; Wang Y; Fong WP; Hu MT; Zheng YC; Zheng Y; Li BK; Yuan YF; Chen G; Pan ZZ; Song L; Li YH; Xu RH
Theranostics; 2021; 11(14):7018-7028. PubMed ID: 34093868
[No Abstract] [Full Text] [Related]
18. A new strategy based on fluorodeoxyglucose-positron emission tomography for managing liver metastasis from colorectal cancer.
Watanabe A; Harimoto N; Araki K; Yoshizumi T; Arima K; Yamashita Y; Baba H; Tetsuya H; Kuwano H; Shirabe K
J Surg Oncol; 2018 Dec; 118(7):1088-1095. PubMed ID: 30261101
[TBL] [Abstract][Full Text] [Related]
19. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival.
Adam R; Delvart V; Pascal G; Valeanu A; Castaing D; Azoulay D; Giacchetti S; Paule B; Kunstlinger F; Ghémard O; Levi F; Bismuth H
Ann Surg; 2004 Oct; 240(4):644-57; discussion 657-8. PubMed ID: 15383792
[TBL] [Abstract][Full Text] [Related]
20. Clinical features and prognosis in hepatectomy for colorectal cancer with centrally located liver metastasis.
Kuo IM; Huang SF; Chiang JM; Yeh CY; Chan KM; Chen JS; Yu MC
World J Surg Oncol; 2015 Mar; 13():92. PubMed ID: 25889950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
